Susquehanna International Group’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $601K | Sell |
|
|||||
|
2022
Q2 | $2.09M | Buy |
|
|||||
|
2022
Q1 | $2.01M | Sell |
|
|||||
|
2021
Q4 | $3.67M | Buy |
|
|||||
|
2021
Q3 | $5.58M | Buy |
|
|||||
|
2021
Q2 | $5.38M | Buy |
|
|||||
|
2021
Q1 | $5.15M | Buy |
|
|||||
|
2020
Q4 | $3.31M | Sell |
|
|||||
|
2020
Q3 | $5.45M | Sell |
|
|||||
|
2020
Q2 | $8.02M | Buy |
|
|||||
|
2020
Q1 | $6.36M | Buy |
|
|||||
|
2019
Q4 | $355K | Sell |
|
|||||
|
2019
Q3 | $467K | Sell |
|
|||||
|
2019
Q2 | $8.13M | Buy |
|
|||||
|
2019
Q1 | $1.54M | Sell |
|
|||||
|
2018
Q4 | $12M | Buy |
|
|||||
|
2018
Q3 | $9.62M | Buy |
|
|||||
|
2018
Q2 | $5.9M | Sell |
|
|||||
|
2018
Q1 | $15M | Sell |
|
|||||
|
2017
Q4 | $24.9M | Buy |
|
|||||
|
2017
Q3 | $9.51M | Buy |
|
|||||
|
2017
Q2 | $4.9M | Sell |
|
|||||
|
2017
Q1 | $7.8M | Buy |
|
|||||
|
2016
Q4 | $4.61M | Sell |
|
|||||
|
2016
Q3 | $7.75M | Buy |
|
|||||
|
2016
Q2 | $858K | Sell |
|
|||||
|
2016
Q1 | $3.81M | Sell |
|
|||||
|
2015
Q4 | $12.9M | Buy |
|
|||||
|
2015
Q3 | $1.01M | Buy |
|
|||||
|
2015
Q2 | $601K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $2.92M | Sell |
|
|||||
|
2014
Q3 | $3.25M | Sell |
|
|||||
|
2014
Q2 | $5.12M | Buy |
|
|||||
|
2014
Q1 | $800K | Sell |
|
|||||
|
2013
Q4 | $3.1M | Buy |
|
|||||
|
2013
Q3 | $320K | Sell |
|
|||||
|
2013
Q2 | $730K | Buy |
|